Plant-Based Biologics Market Research Report: Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021

The Plant-Based Biologics industry world over has witnessed positive growth and is projected to record considerable growth. However, the market is grappled with several challenges and uncertainties due to pandemic and other market factors. But at the same time, there exist multiple opportunities the market players can look at. This report on global Plant-Based Biologics market gives a comprehensive view of all market influencing factors including challenges and opportunities ahead. The report covers all the topics of the market that are sometimes inaccessible to market players. Furthermore, the report gives better understanding of competitive environment that exist in the Plant-Based Biologics industry at local and global level.

Download Sample Copy of this Report: https://www.absolutemarketsinsights.com/request_sample.php?id=791&rp

Plant-Based Biologics Market By Clinical Trial (Phase I, Phase II, Others); By Source (Tobacco, Tobacco Cells, Tobacco Leaves, Nicotiana Benthamiana Leaves, Carrot Cell Culture, Rice Seeds, Moss, Algae, Duckweed Leafy Biomass, Others); By Product (Taliglucerase Alfa, ZMApp, PRX-102, HAI-05, Others); By Diseases (HIV/AIDS, Ebola Virus, Cholera, Leprosy, Tuberculosis, Fabry Disease, Anthrax, Pompe Disease, Influenza (Type A, Type B, Type C), Alzheimer, Respiratory Syndromes, Gaucher Disease, Cancer, Others); By Mode Of Administration (Intramuscular, Oral Administration, Others); By End Users (Hospitals, Clinics, Primary Care Centers, Others);By Region (U.S., Canada, Mexico, Rest Of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest Of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest Of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest Of Middle East & Africa, Brazil, Argentina, Rest Of Latin America) — Global Insights, Growth, Size, Comparative Analysis, Trends And Forecast, 2020–2028

Global plant-based biologics market is anticipated to grow at a CAGR of 26.45% over the forecast period. Some of the players operating in the plant-based biologics market are Byondis, eleva GmbH, Eversea Inc, iBio, Inc, Icon Genetics GmbH, InVitria, Kentucky BioProcessing, Inc., Leaf Expression Systems, Mapp Biopharmaceutical, Inc., Medicago Inc., OnePointOne, Inc., Pfizer Inc., Planet Biotechnology Inc., PlantForm, Protalix Biotherapeutics, Ventria Bioscience Inc., Zea Biosciences, amongst others.

Diseases have been affecting human civilizations since time immemorial. The global disease burden cost billions of dollars in revenue. Companies around the globe, both private and public, are increasingly trying to reduce the impact of diseases on human beings by developing both therapeutic and diagnostic biologics. Biologics, also called as biological drugs, is a product which is derived from living organisms, or contains some components of living organisms. Traditionally, animal-based biologics have been used for the treatment of diseases. Gelatin, for instance, is a partially hydrolysed collagen which is derived from bovine or porcine living organisms. Gelatin forms the basis of numerous capsule shells, and is also being used as a stabilizing agent in pharmaceutical products such as vaccines.

However, religious practices and concerns regarding the humane treatment of animals for developing animal-based vaccines are prompting researches to move towards plant-based biologics. Furthermore, plant-based biologics are also economical to produce on a large scale, as compared to animal-based products. Also, these products have been proven to be effective agents in controlling pathogens, making it suitable for use as food additives. Bacterial colicins, for instance, is derived from plants. Studies show that they can be used as a food additive for keeping food pathogenic bacteria at bay. Such factors are driving the adoption of plant-based biologics market. Escherichia coli strains, which causes food poisoning in human beings, are eliminated in the presence of these colicins in lower concentrations.

The cost of manufacturing a gram of processed colicins is around US$ 1, which makes it viable for commercial use on a large scale. The U.S. Food and Drug Administration Agency has approved the use of these colicins in food products. Compared to the mammalian cell culture processes which are in use currently, plant-based biologics can be produced at a higher pace and greater quantity, without compromising on quality and efficiency. The rising demand for cost-effective drugs and food additives with minimal side effects, coupled with concerns regarding animal abuse for the development of drugs, is paving way for the growth of the global plant-based biologics market.

The COVID-19 pandemic has severely impacted the lives of individuals across the globe. Researches and academicians are increasingly trying to come up with innovative products which can tackle coronavirus. The mutation of the COVID-19 virus is raising concerns regarding the effectiveness of vaccines for controlling the spread of the virus. Plant-based biologics are being touted as a viable alternative for increasing the immunity in individuals, thereby making them more capable in fighting coronavirus. Furthermore, plant-based vaccines are also in development. Texas-based iBio, Inc., for instance, is focussing on the development of therapeutics and vaccines with plant-based products.

ACE2-Fc is a COVID-19 therapeutic which is being developed by iBio, in partnership with Planet Biotech. Also, a couple of vaccines named IBIO-200 and IBIO-201 are in the final stages of development. IBIO-201 is based on a process that combines the antigens from SARS-CoV-2 spike protein and iBio’s LicKM molecule which helps in enhancing immune response in human beings. LicKM technology which is being used by iBio also has the potential of reducing vaccine antigen dose requirements in all age groups, thereby making it cost effective. Hence, the COVID-19 pandemic is expected to have a positive impact on the global plant-based biologics market in the coming years.

This global Plant-Based Biologics market research analysis brings together a vast market place clearly into the focus. By understanding client’s requirements precisely and following them firmly, this Plant-Based Biologics market research report has been structured. The report discusses the recent and future market trends and performs analysis of the impact of buyers, substitutes, new entrants, competitors, and suppliers on the market. The Plant-Based Biologics report also has reviews about key players, major collaborations, merger & acquisitions along with trending innovation and business policies. The Plant-Based Biologics report is generated by proper use of SWOT analysis and Porter’s Five Forces analysis methods.

Opportunities in the Plant-Based Biologics market report:
1. Comprehensive quantitative analysis of the industry is provided for the period of 2021–2030 to assist stakeholders to capitalize on the prevailing market opportunities.
2. Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
3. Comprehensive quantitative analysis of the industry is provided for the period of 2021–2030 to assist stakeholders to capitalize on the prevailing market opportunities.
4. Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Europe.
5. Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Global.

Get More Information : https://www.absolutemarketsinsights.com/reports/Plant-Based-Biologics-2020-2028-791

Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91–740–024–2424, US +1–510–420–1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com